Next Article in Journal
Diversity and Impact of Prokaryotic Toxins on Aquatic Environments: A Review
Next Article in Special Issue
Mechanisms of Cisplatin Nephrotoxicity
Previous Article in Journal
Response to Comments of Peter G. Mantle
Previous Article in Special Issue
Contrasting Nephropathic Responses to Oral Administration of Extract of Cultured Penicillium polonicum in Rat and Primate
Toxins 2010, 2(10), 2340-2358; doi:10.3390/toxins2102340

Genomic Damage in Endstage Renal Disease—Contribution of Uremic Toxins

1,* , 2
1 Institute of Pharmacology and Toxicology, University of Würzburg, Versbacher Straße 9, 97078 Würzburg, Germany 2 Department of Internal Medicine, University of Würzburg, Josef-Schneider-Straße 2, 97080 Würzburg, Germany
* Author to whom correspondence should be addressed.
Received: 27 August 2010 / Revised: 23 September 2010 / Accepted: 26 September 2010 / Published: 11 October 2010
(This article belongs to the Special Issue Renal Toxicity)
View Full-Text   |   Download PDF [136 KB, uploaded 11 October 2010]


Patients with end-stage renal disease (ESRD), whether on conservative, peritoneal or hemodialysis therapy, have elevated genomic damage in peripheral blood lymphocytes and an increased cancer incidence, especially of the kidney. The damage is possibly due to accumulation of uremic toxins like advanced glycation endproducts or homocysteine. However, other endogenous substances with genotoxic properties, which are increased in ESRD, could be involved, such as the blood pressure regulating hormones angiotensin II and aldosterone or the inflammatory cytokine TNF-a. This review provides an overview of genomic damage observed in ESRD patients, focuses on possible underlying causes and shows modulations of the damage by modern dialysis strategies and vitamin supplementation.
Keywords: dialysis; genotoxicity; uremic toxins dialysis; genotoxicity; uremic toxins
This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Share & Cite This Article

Further Mendeley | CiteULike
Export to BibTeX |
MDPI and ACS Style

Schupp, N.; Heidland, A.; Stopper, H. Genomic Damage in Endstage Renal Disease—Contribution of Uremic Toxins. Toxins 2010, 2, 2340-2358.

View more citation formats

Related Articles

Article Metrics

For more information on the journal, click here


Cited By

[Return to top]
Toxins EISSN 2072-6651 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert